@article{3104937,
    title = "Assessing cardiovascular risk in patients with diabetes: An update",
    author = "Damaskos, C. and Garmpis, N. and Kollia, P. and Mitsiopoulos, G. and Barlampa, D. and Drosos, A. and Patsouras, A. and Gravvanis, N. and Antoniou, V. and Litos, A. and Diamantis, E.",
    journal = "Current Cardiology Reviews",
    year = "2020",
    volume = "16",
    number = "4",
    pages = "266-274",
    publisher = "Bentham Science Publishers",
    issn = "1573-403X",
    doi = "10.2174/1573403X15666191111123622",
    keywords = "biological marker;  hemoglobin;  low density lipoprotein;  biological marker, cardiovascular disease;  cardiovascular mortality;  cardiovascular risk;  coronary artery calcification;  coronary artery calcium score;  coronary artery disease;  diabetes mellitus;  diabetic patient;  erectile dysfunction;  gender;  heart ventricle hypertrophy;  human;  hypertension;  ischemic heart disease;  meta analysis (topic);  microalbuminuria;  protein expression;  Review;  risk assessment;  risk factor;  single photon emission computed tomography;  sleep disordered breathing;  systolic blood pressure;  total cholesterol level;  adult;  blood;  cardiovascular disease;  complication;  diabetic complication;  female;  male, Adult;  Biomarkers;  Cardiovascular Diseases;  Diabetes Complications;  Female;  Heart Disease Risk Factors;  Humans;  Male;  Risk Assessment;  Risk Factors",
    abstract = "The globalization of the Western lifestyle has resulted in increase of diabetes mellitus, a complex, multifactorial disease. Diabetes mellitus is a condition often related to the disorders of the cardiovascular system. It is well established that three quarters of diabetics, aged over 40, will die from cardiovascular disease and are more likely than non-diabetics to die from their first cardiovascular event. Therefore, it is of paramount importance to individualize treatment via risk stratifica-tion. Conditions that increase cardiovascular risk in people with diabetes include age more than 40 years, male gender, history of relative suffering from premature CHD, blood pressure and high LDL levels, presence of microalbuminuria, obstructive sleepapnea, erectile dysfunction and other conditions. Several models have been developed in order to assess cardiovascular risk in people with and without diabetes. Some of them have been proven to be inadequate while others are widely used for years. An emerging way of risk assessment in patients with diabetes mellitus is the use of biomark-ers but a lot of research needs to be done in this field in order to have solid conclusions. © 2020 Bentham Science Publishers."
}